Gunderson Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,748
Closed -$281K 52
2020
Q3
$281K Sell
2,748
-5,232
-66% -$547K 0.24% 41
2020
Q2
$809K Sell
7,980
-7,404
-48% -$662K 0.65% 40
2020
Q1
$1.04M Buy
15,384
+2,480
+19% +$154K 1.44% 16
2019
Q4
$706K Buy
12,904
+976
+8% +$46.3K 0.77% 24
2019
Q3
$445K Buy
+11,928
New +$463K 0.44% 33

Other funds holding DXCM

Gunderson Capital Management's DXCM Position: Q4 2020 in Review

Gunderson Capital Management sold out of DexCom (DXCM) in Q4 2020, closing a stake of 2,748 shares — an estimated $281K sold.

Gunderson Capital Management first reported a position in DXCM in Q3 2019 and held it in 5 quarters. The position peaked at $1.04M in Q1 2020. 734 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Gunderson Capital Management reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 2,748 DexCom shares in Q4 2020, an estimated $281K.
  • Gunderson Capital Management first reported a position in DexCom in Q3 2019 and held it in 5 quarters.
  • Gunderson Capital Management's DexCom position peaked at $1.04M in Q1 2020.
  • 734 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Gunderson Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.